Health Care Archives - Page 391 of 478

2 minute read

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

October 12, 5:22 PM

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show.

MRK

1 minute read

Why Evofem Biosciences Shares Are Plunging Today?

By Vandana Singh

October 12, 2:17 PM

Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100) to prevent chlamydia and gonorrhea infection in women but did not achieve its endpoints.

EVFM

1 minute read

Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants

By Vandana Singh

October 12, 11:47 AM

Emergex Vaccines Holding Limited acquired the assets of Zosano Pharma Corporation. The sale was part of the customary proceedings after…

LLY

1 minute read

Moderna In-Licenses Autolus’ Technology For mRNA-Based Cancer Therapeutics

By Vandana Singh

October 12, 11:30 AM

Moderna Inc (NASDAQ:MRNA) has exercised its option to license Autolus Therapeutics plc’s (NASDAQ:AUTL) proprietary binders against an undisclosed immuno-oncology target for…

AUTL

1 minute read

Yet Another Good News For Moderna, FDA Approves Its New Omicron Adapted COVID-19 Shot

By Vandana Singh

October 12, 11:21 AM

Moderna Inc (NASDAQ:MRNA) has received FDA emergency use authorization (EUA) for its BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, in children…

MRK

1 minute read

Amid Plunging COVID-19 Test Sales T2 Biosystems Cuts Annual Guidance, Shares Fall

By Vandana Singh

October 12, 10:59 AM

T2 Biosystems Inc (NASDAQ:TTOO) expects Q3 sales of approximately $3.7 million, including product revenue of around $2.6 million, representing a…

TTOO

1 minute read

Novavax Prototype COVID-19 Vaccine Data Shows Benefit Against Variants

By Vandana Singh

October 12, 10:50 AM

Novavax Inc (NASDAQ: NVAX) presented data from the Phase 3 PREVENT-19 trial and Study 307 (Lot Consistency) at the World Vaccine Congress Europe 2022.

NVAX

1 minute read

Moderna Shares Are Surging After Merck Exercised Personalized Cancer Vaccine Pact

By Vandana Singh

October 12, 9:26 AM

Moderna Inc (NASDAQ:MRNA) said Merck & Co Inc (NYSE:MRK) had exercised an option to jointly develop and potentially sell personalized mRNA-based cancer vaccine.…

MRK

1 minute read

US Health Official Says Updated COVID-19 Boosters Should Offer Protection Amid Tracking Emerging Variants

By Vandana Singh

October 12, 8:03 AM

The U.S. health officials are tracking several coronavirus omicron subvariants that more easily evade immunity, rendering many treatments ineffective. But the new booster shots should provide protection, said Dr. Ashish Jha, head of the White House Covid task force.

MRNA

1 minute read

EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition

By Vandana Singh

October 12, 7:31 AM

Pasithea Therapeutics Corp (NASDAQ: KTTA) has acquired AlloMek Therapeutics LLC, a privately-held biotechnology company,

KTTA